(AGENPARL) – OXFORD ven 14 aprile 2023
Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue.
The study (reported in Lancet eClinical Medicine) found participants given the treatment, developed by US pharmaceutical company Axcella Therapeutics, reported feeling less fatigued than those given a placebo.
Fonte/Source: https://www.ox.ac.uk/news/2023-04-14-trial-investigating-potential-treatment-fatigue-relief-people-long-covid-reports